Severe Preeclampsia
32
0
0
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.3%
2 terminated out of 32 trials
88.2%
+1.7% vs benchmark
13%
4 trials in Phase 3/4
13%
2 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (32)
Excess Base Comparison Between Pregnant Subjects With Severe Preeclampsia vs. Normotensive Pregnant Women
Identification of Genes of Interest for Severe Forms of Preeclampsia
Algorithm-Based Timing of Delivery Using the sFlt-1/PlGF Ratio in Early-Onset Severe Preeclampsia. (MAP 2 Study : Management Based on Angiogenic Markers in Preeclampsia 2 Study )
Furosemide vs Placebo in Severe Preeclampsia Postpartum
Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia
Factors Associated With Blood Pressure Control Failure to Intravenous Labetalol in Severe Preeclampsia
Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure
Diastolic Dysfunction 2025
The Association Between Different Markers With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia
Serum Magnesium Concentration in Magnesium Sulfate Therapy for Severe Preeclampsia
Protocols for Magnesium Sulfate Maintenance Dose in Overweight and Obese Women Diagnosed With Preeclampsia
Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia.
Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine
Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia
Complement Regulation to Undo Systemic Harm in Preeclampsia
Comparison of Loading Dose Magnesium Sulphate With Prichard Regimen in the Management of Severe Preeclampsia and Eclampsia.
Nitroglycerin Versus Labetalol in Acute Severe Pre-eclampsia
Ultrasonographic Diameter of Optic Nerve Sheath in Fluid Assessment in Severe Preeclamptic Patients
Risk Prediction Models for Adverse Maternal and Neonatal Outcomes in Preeclampsia
Serum Magnesium Level Administration in Severe Pre-eclampsia Obese Pregnancy